Percutaneous coronary interventions (PCIs) have become the most commonly performed coronary revascularization procedures. At the same time, there is an increased likelihood that patients with intracoronary stents will need to undergo surgery. Two serious consequences emerge from this situation: (i) stent thrombosis in relation to discontinuation of antiplatelet therapy, and (ii) major bleeding in relation to continuation of antiplatelet therapy. The best solution to overcome the risks resulting from surgery performed in patients after stent implantation is to postpone the operation until after re-endothelialization of the vessel surface is completed. Expert recommendations advise that patients can be sent for non-cardiac surgery 3 months after bare-metal stent PCI and 12 months after drug-eluting stent PCI, with continuation of aspirin therapy. Difficult decisions regarding antiplatelet management arise when a patient that is still receiving dual antiplatelet therapy with aspirin and a thienopyridine has to undergo surgery that cannot be postponed. Discussions between the treating cardiologist, the surgeon and the anaesthesiologist about this situation are recommended in order to achieve a reasonable expert consensus.

3rd Medical Faculty of Charles University and University Hospital Kralovske Vinohrady Prague CzechRepublic

Zobrazit více v PubMed

Ann Thorac Surg. 2010 Feb;89(2):397-402 PubMed

Circ Cardiovasc Interv. 2009 Jun;2(3):213-21 PubMed

Circulation. 2004 Sep 7;110(10):1202-8 PubMed

CMAJ. 2005 Sep 27;173(7):779-88 PubMed

J Am Coll Cardiol. 2006 Jul 4;48(1):193-202 PubMed

Br J Anaesth. 2006 Oct;97(4):582; author reply 582 PubMed

BMJ. 1994 Jan 8;308(6921):81-106 PubMed

J Intern Med. 2005 May;257(5):399-414 PubMed

Circulation. 2009 Dec 22;120(25):2577-85 PubMed

Anesthesiology. 2008 Oct;109(4):588-95 PubMed

Lancet. 2009 Mar 14;373(9667):897-910 PubMed

Clin Res Cardiol. 2007 Jun;96(6):375-82 PubMed

Circulation. 2009 Jun 9;119(22):2936-44 PubMed

J Am Coll Cardiol. 2009 Jun 2;53(22):2019-27 PubMed

N Engl J Med. 2009 Dec 10;361(24):2318-29 PubMed

Anesth Analg. 2001 Mar;92(3):572-7 PubMed

Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):48-52 PubMed

Eur Heart J. 2006 Nov;27(22):2667-74 PubMed

N Engl J Med. 2004 Dec 30;351(27):2795-804 PubMed

Am J Cardiol. 2009 Nov 1;104(9):1229-34 PubMed

J Am Coll Cardiol. 2007 Feb 13;49(6):734-9 PubMed

Eur Heart J. 2005 Jun;26(12):1169-79 PubMed

J Am Coll Cardiol. 2007 Jan 2;49(1):122-4 PubMed

Anesth Analg. 2005 Jun;100(6):1576-1583 PubMed

Eur J Vasc Endovasc Surg. 1997 Apr;13(4):375-80 PubMed

Eur Heart J. 2009 Nov;30(22):2769-812 PubMed

Eur Heart J. 2009 Nov;30(22):2714-21 PubMed

J Am Coll Cardiol. 2000 Jan;35(1):157-63 PubMed

Am Heart J. 2006 Jan;151(1):185-91 PubMed

Am Heart J. 2006 Mar;151(3):689.e1-689.e10 PubMed

Br J Anaesth. 2010 Mar;104(3):285-91 PubMed

Lancet. 2008 Jul 12;372(9633):139-44 PubMed

Circulation. 2011 Feb 22;123(7):779-97 PubMed

Anesthesiology. 2008 Oct;109(4):596-604 PubMed

Circulation. 2006 Feb 14;113(6):e85-151 PubMed

Chest. 2006 Aug;130(2):584-96 PubMed

Circulation. 2007 Oct 23;116(17):e418-99 PubMed

Br J Anaesth. 2000 Jul;85(1):109-17 PubMed

J Am Coll Cardiol. 2009 Apr 21;53(16):1399-409 PubMed

EuroIntervention. 2008 Jan;3(4):442-6 PubMed

Stroke. 2000 Jul;31(7):1779-84 PubMed

J Am Coll Cardiol. 2007 May 1;49(17):1763-9 PubMed

Br J Anaesth. 2006 Jun;96(6):686-93 PubMed

Perioperative cardiovascular complications versus perioperative bleeding in consecutive patients with known cardiac disease undergoing non-cardiac surgery. Focus on antithrombotic medication. The PRAGUE-14 registry